Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-7-19
|
pubmed:abstractText |
According to Jerne's network hypothesis, the unique amino acid sequences of Ig variable regions, that is, the idiotypic determinants can function in immunoregulatory mechanisms and cellular interactions. Indeed, Id-specific T-cells (mostly CD4+) have since been described, but the nature of Id-positive Ig on B-cells involved in recruiting T-cells is unclear. Studies from our ongoing investigation presented here clearly show that Id can evoke both CD4+ and CD8+ T cells, and exist not only as the integral components of a bona fide antigen-binding receptor Ig but also as distinct molecular entities in processed forms on the cell surface of B-lymphocytes. Using a B-cell hybridoma, 2C3, that expresses anti-hapten (phthalate) antibody receptors on the cell surface, we induced both Id-specific CD4+ and CD8+ T effector cells. The CD4+ T cells were suppressive and mediated generation of Id-loss 2C3 variants, whereas CD8+ T cells were highly cytotoxic and selectively eliminated 2C3 cells both in vitro and in vivo. These effector cells could be induced by cell membrane-associated Ig but not by its soluble form, secreted by 2C3 cells. Antibodies to MHC class I but not class II molecules were inhibitory to this induction. Furthermore, brefeldin A (BFA), an inhibitor of MHC class I mediated processing, blocked induction of CTL but had no effect on the expression of membrane Ig. Moreover, chloroquine, an inhibitor of class II-mediated processing, had no effect. A few reports have recently appeared indicating that an exogenous Ig can be processed by B-cells in the context of MHC class II proteins.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0301-1208
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
414-21
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7911781-Animals,
pubmed-meshheading:7911781-Antigen-Presenting Cells,
pubmed-meshheading:7911781-Antigens, CD4,
pubmed-meshheading:7911781-Antigens, CD8,
pubmed-meshheading:7911781-B-Lymphocytes,
pubmed-meshheading:7911781-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7911781-Hybridomas,
pubmed-meshheading:7911781-Immunoglobulin Idiotypes,
pubmed-meshheading:7911781-Immunoglobulin Variable Region,
pubmed-meshheading:7911781-Mast-Cell Sarcoma,
pubmed-meshheading:7911781-Mice,
pubmed-meshheading:7911781-Mice, Inbred BALB C,
pubmed-meshheading:7911781-Spleen,
pubmed-meshheading:7911781-T-Lymphocytes, Cytotoxic
|
pubmed:year |
1993
|
pubmed:articleTitle |
Immunoregulation by processed immunoglobulin on B-cells.
|
pubmed:affiliation |
Department of Life Sciences, Indiana State University, Terre Haute 47809.
|
pubmed:publicationType |
Journal Article
|